--AstraZeneca has held talks to combine with Bristol Myers Squibb, the Financial Times reports, citing unnamed sources.
--AstraZeneca has held talks to combine with Bristol Myers Squibb, the Financial Times reports, citing unnamed sources.
--The U.K. drugmaker discussed a tie-up with its U.S. rival in recent months, and the talks could lead to a deal or fall apart, according to the FT.
--AstraZeneca declined to comment and BMS didn't respond to requests for comment, according to the FT.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
AstraZeneca, Bristol Myers are in talks about merger — report
Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
AstraZeneca said to have explored Bristol Myers merger | Fortune
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
AstraZeneca in talks over £300bn mega-merger with US rival – reports
UK's AstraZeneca eyeing $400b merger, report says
AstraZeneca Stock Nosedives On Mega-Merger Rumor
AstraZeneca, BMS discuss $400B pharma mega-deal
